By Damien Jaton
It’s time for biotech to plan with the same precision it uses to develop therapies.
In today’s fast-evolving biotech landscape, scientific discovery is moving faster than ever. However, while R&D is accelerating, many biotech companies are still struggling with outdated planning practices, particularly in the clinical supply chain. Spreadsheets, fragmented systems, and isolated teams lead to inefficiencies that delay trials, waste resources, and limit scalability.
It’s time for a new mindset: one that treats planning not as a back-office function, but as a strategic enabler. From clinical forecasting to supply chain execution, biotech companies need to adopt advanced planning tools and processes that are agile, integrated, and built for complexity.
The Planning Gap in Biotech
Most biotech firms are born as lean, science-driven organizations. Planning tends to happen in Excel or disconnected ERP systems. But as trials scale and global complexity grows, this approach breaks down:
- Clinical teams manually forecast patient visits without aligning them with supply plans.
- Regulatory requirements are tracked separately, which risks last-minute relabelling.
The clinical supply chain operates reactively, which leads to overstocking, rushed shipments, and stockouts.
At the same time, many biotech companies are intensely focused on day-to-day execution: running trials, hitting recruitment targets, meeting regulatory milestones. With so much effort going into operational delivery, planning often becomes reactive or overlooked altogether. But having a good process is what allows teams to step back and see the bigger picture and ultimately make smarter decisions. The result? Slowdowns, budget overruns, and missed milestones that frustrate teams and investors alike.
Why ERP isn’t enough
ERP systems are essential for executing transactions, tracking inventory, managing purchase orders, and controlling batches. However, they are limited when it comes to forward-looking scenario planning, demand modeling, and what-if simulations.
In the biotech industry, where patient enrolment can change quickly, regulatory rules vary by country, and product shelf life is crucial, static ERP planning is insufficient.
Enter APS: advanced planning & scheduling for Biotech.
APS tools are built to handle the complexity of modern clinical supply chains. They allow companies to:
- Forecast demand based on real-time patient enrolment and trial protocols
- Plan production and packaging based on visit schedules and regional requirements
- Optimize inventory across global depots to avoid waste and delays.
- Run scenarios for delays, shortages, or protocol changes
APS becomes even more powerful when embedded in a connected platform like Anaplan. It links clinical, supply chain, and regulatory planning into a single source of truth.
Scenario planning: the new Biotech superpower
Scenario planning is essential for resilience, not just a nice-to-have. Biotech companies can use it to answer questions such as:
- What would happen if recruitment in Europe were delayed by three months?
- How would a new labelling requirement in Japan affect our packaging lead times?
- Can we reallocate inventory if enrolment spikes in a specific region?”
This proactive approach reduces risk, increases agility, and enables better decision-making at every level of the organization.
However, scenario planning involves more than answering isolated questions. It’s about developing a structured capability to test assumptions, quantify risk, and proactively guide decisions.
Most importantly, scenarios aren’t built once and forgotten; they evolve. Modern platforms allow users to update key drivers in real time and immediately see the impact of those changes on plans. This helps teams act with speed and confidence, even when things don’t go according to plan, which they often don’t. Scenario planning brings science and operations closer together. It helps biotech companies transition from gut-feel decisions to data-driven, cross-functional alignment.
Conclusion: planning is a strategic advantage
Biotech companies can no longer afford to treat planning as a secondary or separate function. With increasing pressure to deliver faster, expand globally, and maintain compliance, the clinical supply chain must become more efficient.
Advanced planning tools, such as advanced planning software (APS), scenario modelling, and supply chain planning software, are not just for big pharma anymore. These tools are essential for helping biotech organizations confidently transition from the lab to launch.
Are you ready to rethink your planning approach? Learn how the BioScale App can help your team scale smarter, adapt faster, and gain visibility into every part of the clinical supply chain.